Learn more about the benefits and global adoption of IORT technology for breast applications with the ‘IORT Special Report’ - featuring a collection of peer-reviewed articles.

Simply fill in your details below for your free copy or call us on 01223 679779:

Unable to load form.


Melding two worlds into one benefit.

Combining surgery and radiotherapy, ZEISS INTRABEAM 600 enables an individual IORT treatment ensuring that skin and deeper structures are protected and a shorter duration of the radiation therapy compared to external beam radiation therapy (EBRT). This can also reduce associated side effects and enhances treatment comfort for the patient – a key element in increased quality of life.1

1 Vaidya, J. S. et al. (2020). Long-term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ, 370, m2836. https://doi.org/10.1136/bmj.m2836